| Literature DB >> 30513983 |
Hamid Reza Mozaffari1,2, Elisa Zavattaro3, Abas Abdolahnejad4, Pia Lopez-Jornet5, Neda Omidpanah6, Roohollah Sharifi7, Masoud Sadeghi8,9, Mohammad Shooriabi10, Mohsen Safaei11.
Abstract
Immunoglobulins (IgA, IgG, and IgM) are significant anti-inflammatory factors. The meta-analysis aimed to assess the serum and salivary levels of Igs as more important immunoglobulins in patients affected by oral lichen planus (OLP) compared to the healthy controls. Four databases, including PubMed/Medline, Scopus, Web of Science, and Cochrane Library as well as Iranian databases were checked up to January 2018 without language restriction. The quality of each involved study was done using the Newcastle⁻Ottawa Quality Assessment Scale (NOS) questionnaire. A random-effects model analysis was done by RevMan 5.3 software applying the mean difference (MD) plus 95% confidence intervals (CIs). The CMA 2.0 software was applied to calculate the publication bias among the studies. Out of 70 studies found in the databases, 8 studies were involved and analyzed in the meta-analysis. The meta-analysis included 282 OLP patients and 221 healthy controls. The pooled MDs of serum levels of IgA, IgG, and IgM were -0.13 g/L [95% CI: -0.24, -0.02; P = 0.02], 1.01 g/L [95% CI: -0.91, 2.93; P = 0.30], and -0.06 g/L [95% CI: -0.25, 0.14; P = 0.56], respectively; whereas, the salivary IgA and IgG levels were 71.54 mg/L [95% CI: 12.01, 131.07; P = 0.02] and 0.59 mg/L [95% CI: -0.20, 1.38; P = 0.14], respectively. Considering the few studies performed on saliva, the results suggested that the salivary levels, especially IgA level had higher values than the serum levels. Therefore, the salivary immunoglobulins can play a significant function in the OLP pathogenesis.Entities:
Keywords: immunoglobulin; oral lichen planus; saliva; serum
Mesh:
Substances:
Year: 2018 PMID: 30513983 PMCID: PMC6306895 DOI: 10.3390/medicina54060099
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1Flow-chart of the study.
Characteristics of the studies included in the meta-analysis (n = 8).
| First Author (year) | Country | Number of Patients/Mean Age (year)/Male% | Number of Controls/Mean Age (year)/Male% | IgA | IgG | IgM | Method |
|---|---|---|---|---|---|---|---|
| Scully, 1982 [ | Scotland | 35 | 27 | Serum | Serum | Serum | Modified single radial |
| Sklavounou, 1983 [ | Greece | 50 | 20 | Serum | Serum | Serum | The single radial |
| Lundström, 1985 [ | Sweden | 34 | 23 | Serum | Serum | Serum | IgG (immunochemical turbidimetric) and IgA and IgM (electroimmuno |
| Sistig, 2002 [ | Croatia | 65 | 20 | Saliva | Saliva | - | IgG (ELISA) and IgA (radial |
| Ghaleyani, 2012 [ | Iran | 44 | 44 | Saliva | Saliva | - | IgA (Human IgA Saliva Diametra kit, the binding Site, Italy), and IgG (radial immunodiffusion) |
| Mehdipour, 2013 [ | Iran | 50 | 25 | Serum | Serum | Serum | Autoanalyzer (Abbot- alcion, USA) and Pars Azmon kits |
| Divya, 2014 [ | India | 30 | 30 | Serum | Serum | - | Dade Behring BN ProSpec Nephelometer |
| Lopez-Jornet, 2016 [ | Spain | 33 | 32 | Saliva | - | - | ELISA kit (Bethyl, |
Abbreviations: Ig, immunoglobulin; ELISA, enzyme-linked immunosorbent assay.
Figure 2Forest plot of random-effects of serum immunoglobulins (IgA, IgG, and IgM) levels in oral lichen planus (OLP) patients compared to the healthy controls.
Figure 3Forest plot of random-effects of salivary immunoglobulins (IgA and IgG) levels in oral lichen planus (OLP) patients compared to the healthy controls.
Quality ratings for the studies included on the basis of Newcastle–Ottawa quality assessment scale (n = 8).
| First Author (Year) | Selection | Comparability * | Outcome | Total Score | Quality | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Case Definition Adequate | Representativeness of the Cases | Selection of Controls | Definition of Controls | Main Factor | Additional Factor | Ascertainment of Exposure | Same Method of Ascertainment for Cases and Controls | Non-Response Rate | |||
| Scully, 1982 [ | * | * | - | * | * | * | * | * | - | 7 | Good |
| Sklavounou, 1983 [ | * | * | - | * | * | - | * | * | - | 6 | Fair |
| Lundström, 1985 [ | * | * | - | * | * | * | * | * | - | 7 | Good |
| Sistig, 2002 [ | * | * | - | * | - | - | * | * | - | 5 | Fair |
| Ghaleyani, 2012 [ | * | * | - | * | * | * | * | * | - | 7 | Good |
| Mehdipour, 2013 [ | * | * | - | * | * | * | * | * | - | 7 | Good |
| Divya, 2014 [ | * | * | * | * | * | * | * | * | - | 8 | Good |
| Lopez-Jornet, 2016 [ | * | * | - | * | * | * | * | * | - | 7 | Good |
|
| 6.75 | ||||||||||
* One star for age-matching (Main Factor) and another star (Additional Factor) for sex-matching.
Figure 4Funnel plot of (A) the serum levels and (B) salivary levels of immunoglobulins.